Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
NeuroMetrix Inc
NUROCurrent price
3.82 USD
+0.0085 USD (+0.22%)
Last closed
4.05 USD
Company
www.neurometrix.com
ISIN
US6412558073
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
8 103 480 USD
Yield for 12 month
-30.80 %
1Y
3Y
5Y
10Y
15Y
NURO
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. Address: 4B Gill Street, Woburn, MA, United States, 01801
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
50 USDP/E ratio
–Dividend Yield
–Current Year
+5 901 425 USD
Last Year
+8 256 073 USD
Current Quarter
+769 148 USD
Last Quarter
+1 093 556 USD
Current Year
+3 947 413 USD
Last Year
+5 750 240 USD
Current Quarter
+491 919 USD
Last Quarter
+517 017 USD
Key Figures NURO
1 year
3 years
5 years
10 years
EBITDA
-8 235 133 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.94 %
PEG Ratio
-0.01
Return On Equity TTM
-40.99 %
Wall Street Target Price
50 USD
Revenue TTM
4 383 614 USD
Book Value
8.59 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-53.5 %
Dividend Yield
–
Gross Profit TTM
5 750 240 USD
Earnings per share
-5.44 USD
Diluted Eps TTM
-5.44 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-181.03 %
Dividend Analytics NURO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NURO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
28.03.2007
Forward Annual Dividend Yield
–
Last Split Factor
1:8
Payout Ratio
–
Last Split Date
22.11.2023
Dividend Date
19.11.2019
Stock Valuation NURO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.245
Price Sales TTM
1.8486
Enterprise Value EBITDA
1.4581
Price Book MRQ
0.4681
Financials NURO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NURO
For 52 weeks
2.66 USD
6 USD
50 Day MA
3.61 USD
Shares Short Prior Month
22 548
200 Day MA
3.69 USD
Short Ratio
1.06
Shares Short
28 123
Short Percent
1.41 %
BeatStart